Physician

Kevin Diasti

According to 2025 Medicare claims, Kevin Diasti (NPI: 1376049304) practices hematology/oncology in the Arlington-Alexandria-Reston, VA-WV market, with the plurality of this provider's patient population coming from Loudoun, VA. This provider's primary affiliated billing organization is VIRGINIA CANCER SPECIALISTS, P.C. (NPI: 1346294519; TIN: 541795091) and primary practice location at 20190-5901.

Diasti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 158 traditional Medicare patients, billed 35,382 HCPCS/CPT codes, and received $667,601 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 72 prescription claims across 20 beneficiaries totaling $165,705 in drug costs, led by Letrozole (Letrozole). Open Payments data shows 12 records totaling $456. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,042 to $165,705. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$334K$668K2024 Medicare payment: $667,601 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202415835,382$667,601

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$133K$267K2018 Drug cost: $12,042 (USD; Tot_Drug_Cst)2019 Drug cost: $17,128 (USD; Tot_Drug_Cst)2020 Drug cost: $35,945 (USD; Tot_Drug_Cst)2021 Drug cost: $9,579 (USD; Tot_Drug_Cst)2022 Drug cost: $4,315 (USD; Tot_Drug_Cst)2023 Drug cost: $266,501 (USD; Tot_Drug_Cst)2024 Drug cost: $165,705 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181546$12,042
201932211$17,128
202052416$35,945
202133276$9,579
20223794$4,315
20231272$266,501
20242072$165,705

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more4051$77
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less2836$53
80053Blood test, comprehensive group of blood chemicals3338$10
36415Insertion of needle into vein for collection of blood sample4366$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count4163$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LetrozoleLetrozole16540$224

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$456Myriad Genetic Laboratories, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kevin Diasti?

Tedicare shows public-source Medicare data for Kevin Diasti (NPI 1376049304), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kevin Diasti have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kevin Diasti?

Kevin Diasti is linked to VIRGINIA CANCER SPECIALISTS, P.C. (billing NPI 1346294519) in the available physician profile data.

Does Kevin Diasti have Open Payments data?

Kevin Diasti has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.